Elevated creatine phosphokinase and rhabdomyolysis associated with elexacaftor/tezacaftor/ivacaftor use in cystic fibrosis.

Autor: McKinzie CJ; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA., Kam CW; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA., Jones MC; Department of Pharmacy, University of North Carolina Medical Center, Chapel Hill, North Carolina, USA., Gifford LB; Division of Pulmonary Diseases & Critical Care Medicine, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Loughlin CE; Division of Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Noah TL; Division of Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Shenoy VK; Division of Gastroenterology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA., Dellon EP; Division of Pulmonology, Department of Pediatrics, University of North Carolina School of Medicine, Chapel Hill, North Carolina, USA.
Jazyk: angličtina
Zdroj: Pediatric pulmonology [Pediatr Pulmonol] 2024 Jun; Vol. 59 (6), pp. 1795-1797. Date of Electronic Publication: 2024 Mar 22.
DOI: 10.1002/ppul.26980
Databáze: MEDLINE